BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Tuesday, April 23, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Jan. 16, 2001
View Archived Issues
Esperion Therapeutics begins phase IIa evaluation of LUV
Read More
Versicor and Biosearch Italia strengthen BIOCOR antiinfective alliance
Read More
Synapse's p97 delivers doxorubicin across BBB in preclinical study
Read More
Xcytrin clinical development program update
Read More
Microcide and J&J companies sign new and amend existing research agreement
Read More
Topical drug delivery technologies licensed by SkyePharma
Read More
Vertex updates progress during past year, provides outlook for this year
Read More
Corixa's RC-529 adjuvant enters phase III for HBV
Read More
Pharmacological characterization of S-18616, a highly potent and selective alpha2-AR agonist
Read More
Innogenetics' HCV therapeutic successfully completes phase I and moves towards phase II
Read More
LIPID substudy confirms beneficial effects of pravastatin in patients with unstable angina
Read More
Viventia Biotech's melanoma vaccine is safe and immunogenic
Read More
Anti-vWF MAb prevents thrombus deposition and neointima formation in guinea pigs
Read More
Protein Design Labs begins phase I/II trial with SMART antibody for Crohn's disease
Read More
Aurora Biosciences and GSK enter ion channel agreement
Read More
European marketing approval announced for noninvasive lung cancer diagnostic
Read More
Watson's Aslera scheduled for March FDA Arthritis Advisory Committee review
Read More
Proteomics-based RA diagnostics alliance formed by Roche and Millennium
Read More
UCB's nonsedating antihistamine approved in Germany
Read More
Authorization for pivotal trials of Generx sought in U.S.
Read More
Aixlie licenses cancer- and immune-related technologies from Ohio State
Read More
Successful phase I results for Enzo Biochem's HIV-1 gene medicine HGTV-43
Read More
Knoll patents compounds useful for depression and other disorders
Read More
Benzenesulfonamide-based inhibitors of ATP-sensitive K+ channels
Read More
DPP IV inhibitors synthesized at MCRF and their use
Read More
Sankyo's new HIV protease inhibitors show nanomolar activity
Read More
Japanese lab presents new series of TNF-alpha production inhibitors
Read More
Natural compounds for obesity with affinity for NPY receptors
Read More